InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PALVELLA THERAPEUTICS, INC.

PVLA Clue Score43
United States Fiscal year ends December CIK 0001583648 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
George M Jenkins
30 Mar 2026
Director
Buy
445
$112.30
$49.97K
Elaine J Heron
27 Feb 2026
Director
Buy
2,400
$125.00
$300.00K
George M Jenkins
27 Feb 2026
Director
Buy
4,000
$125.00
$500.00K
George M Jenkins
9 Apr 2025
Director
Buy indirect
2,490
$20.27
$50.47K
George M Jenkins
9 Apr 2025
Director
Buy
2,500
$20.13
$50.33K
George M Jenkins
18 Dec 2024
Director
Buy
4,000
$12.93
$51.72K
ADAR1 Capital Management, LLC
12 Aug 2024
10% owner
Buy indirect
757
$15.88
$12.02K
ADAR1 Capital Management, LLC
12 Aug 2024
10% owner
Buy indirect
2,243
$15.88
$35.62K
ADAR1 Capital Management, LLC
9 Aug 2024
10% owner
Buy indirect
3,000
$14.89
$44.68K
James A Geraghty
7 Aug 2024
Director
Buy
1
$1.00
$1.00
Christopher P Kiritsy
25 May 2023
Director
Buy
10,000
$0.85
$8.50K
Tim Demuth
13 May 2022
Chief Medical Officer
Buy
6,000
$1.71
$10.26K
Christopher P Kiritsy
14 Sep 2018
Director
Buy
5,000
$5.11
$25.53K
James A Geraghty
15 May 2018
Director
Buy
10,000
$5.75
$57.50K
Allan Reine
17 Aug 2017
See Remarks
Buy
20,000
$4.89
$97.80K
James A Geraghty
17 Aug 2017
Director
Buy
10,000
$4.82
$48.20K
Allan Reine
16 Aug 2017
See Remarks
Buy
45,000
$4.79
$215.55K
Show all 96 transactions →

What was left out

Form 4 filings counted 177
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 43
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 5,690,810
Sales filed before the plan box existed 8
History held since 8 Jul 2015